2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure

Published 8 August 2024

Michelle M. Kittleson, MD, PhD, FACC, FAHA, FHFSA, Chair; Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA; Boback Ziaeian, MD, PhD, FACC, FAHA, JCPM Liaison*; David Aguilar, MD, MSc, FAHA; Vanessa Blumer, MD; Biykem Bozkurt, MD, PhD, FACC, FAHA, FHFSA; Rebecca L. Diekemper, MPH; Michael P. Dorsch, PharmD, MS, FACC, FAHA; Paul A. Heidenreich, MD, MS, FACC, FAHA; Corrine Y. Jurgens, PhD, RN, ANP, FAHA, FHFSA§; Prateeti Khazanie, MD, MPH, FAHA; George Augustine Koromia, MD, MMCi, FACC; Harriette G.C. Van Spall, MD, MPH

• Advanced Heart Failure & Transplantation
• Cardiology
• Endorsement
• Joint Statement
• Publications & Journals
• Standards & Guidelines

This document describes performance measures for heart failure and is meant to serve as a focused update of the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Measure sets developed by the ACC/AHA are intended to provide practitioners and institutions that deliver cardiovascular services with tools to measure the quality of care provided and identify opportunities for improvement.

Writing committees are instructed to consider the methodology of performance measure development and to ensure that the measures developed are aligned with ACC/AHA clinical practice guidelines. The writing committees are also charged with constructing measures that maximally capture important aspects of care quality, including timeliness, safety, effectiveness, efficiency, equity, and patient-centeredness, while minimizing, when possible, the reporting burden imposed on hospitals, practices, and practitioners

The International Society for Heart and Lung Transplantation (ISHLT) endorsed this document in 2024.